Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CompumedicsASX:CMP +7.84%49 EV-to-OCF is 8.92 as of Sep. 02, 2026, which is 78% below its 10-year median of 40.80. GuruFocus rates ASX:CMP with a GF Score™ of 49/100 and a GF Value™ of A$0.30 (Fairly Valued). The stock has 5 warning signs investors should review. Among 850 Medical Devices & Instruments companies, Compumedics ranks worse than 52.12% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Compumedics's Enterprise Value is A$58.90 Mil.
Compumedics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was A$6.61 Mil. Therefore, Compumedics's EV-to-OCF for today is 8.92.
The historical rank and industry rank for Compumedics's EV-to-OCF or its related term are showing as below:
ASX:CMP'
s EV-to-OCF Range Over the Past 10 Years
Min: 5.68 Med: 40.8 Max: 1799.76
Current: 8.92
During the past 13 years, the highest EV-to-OCF of Compumedics was 1799.76. The lowest was 5.68. And the median was 40.80.
ASX:CMP's EV-to-OCF is ranked worse than 52.12% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 7.815
vs ASX:CMP: 8.92
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Compumedics's PE Ratio (TTM) for today is calculated as:
Compumedics's share price for today is A$0.275.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Compumedics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was A$0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Compumedics EV-to-OCF Related Terms
Compumedics EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Compumedics's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Compumedics's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Compumedics EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Compumedics's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Compumedics's EV-to-OCF falls into.
Compumedics's current Enterprise Value is A$58.90 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Compumedics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was A$6.61 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Compumedics (ASX:CMP) has a EV-to-OCF of 8.92 as of Sep. 02, 2026. This is 78% below median its historical median of 40.80. Over the past decade, Compumedics' EV-to-OCF has ranged from 5.68 to 1,799.76. According to the industry distribution chart, Compumedics ranks #443 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 52.1%.
Is Compumedics' EV-to-OCF too high?
Compumedics' current EV-to-OCF of 8.92 is 78% below median its 10-year median of 40.80. Over the past 10 years, this metric has ranged from a low of 5.68 to a high of 1,799.76. The Medical Devices & Instruments industry median EV-to-OCF is 7.82. Compumedics' value of 8.92 is 14.1% above this industry median. Based on the distribution chart, Compumedics ranks #443 out of 850 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Compumedics has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Compumedics' EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Compumedics ranks #443 out of 850 companies for EV-to-OCF. This places Compumedics in the lower half of its industry. The industry median EV-to-OCF is 7.82. Compumedics' value of 8.92 is 14.1% above this benchmark. Historically, Compumedics' own EV-to-OCF has ranged from 5.68 to 1,799.76 over the past decade. While the company's 10-year median is 40.80 vs. the industry median of 7.82, Compumedics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.82, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Compumedics's current EV-to-OCF of 8.92 is 14.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Compumedics's current EV-to-OCF is 8.92, which is 78% below median its own 10-year median of 40.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compumedics stock overvalued right now?
Based on GuruFocus' analysis, Compumedics (ASX:CMP) is currently considered Fairly Valued. The stock's GF Value™ is A$0.30, compared to a current price of A$0.28 — trading 8.3% below its estimated fair value. The current EV-to-OCF is 8.92, which is 78% below median its 10-year median of 40.80 and 14.1% above the Medical Devices & Instruments industry median of 7.82. Compumedics' overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Compumedics (ASX:CMP), the current EV-to-OCF is 8.92 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Compumedics (ASX:CMP) Overvalued in 2026?
Based on GuruFocus' analysis, Compumedics stock appears to be undervalued.
The current stock price of A$0.28 is trading 8.3% below its estimated GF Value™ of A$0.30.
GuruFocus considers Compumedics to be Fairly Valued.
Key valuation signals for ASX:CMP:
EV-to-OCF: 8.92 (78% below median its 10-year median of 40.80)
GF Value™: A$0.30 vs. price of A$0.28 (8.3% below fair value)
Industry Position: 14.1% above the Medical Devices & Instruments median (#443 of 850)
No single metric tells the full story. See the ASX:CMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
49GF Score
Get the complete analysis for ASX:CMP
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CMP has been successfully added to your 
